αCD40 therapy resulted in a significant reduction in measurable M-protein levels in serum and a decrease in tumor burden in the spleen, whereas only a slight trend could be observed in the BM (Fig. 6 B).
← all excerpts
A single-cell transcriptomic map of the murine and human multiple myeloma immune microenvironment across disease stages.
1
—
—